A Study on the Effect of Mangalyam Tail Nasya in treatment of Facial Palsy (Ardita)

CLINICAL STUDY TO EVALUATE THE EFFICACY OF MANGALYAM TAIL NASYA IN THE MANAGEMENT OF ARDITA (FACIAL PALSY) - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093504

Enrollment

Registered

2025-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G510- Bells palsy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age 19 to 68 years. patient those having Lakshana of Ardita for less than 1 year. Patients willing to sign written consent for participation in the study. Patient fit for Nasya Karma.

Exclusion criteria

Exclusion criteria: The chief exclusion criteria are tumor, intracranial hemorrhage, bilateral facial palsy. Pregnant women and lactating mothers. Patients with uncontrolled diabetes mellitus (DM2).

Design outcomes

Primary

Measure	Time frame
It is expected that at the end of the study we would be able to demonstrate the effect of Mangalyam tail nasya in the management of Ardita (Facial palsy).Timepoint: 12 months	—

Secondary

Measure	Time frame
It is further expected that this study would be able to provide conclusive inputs to assess the efficacy of the Ayurvedic management of Ardita (Facial paralysis)Timepoint: 11 months	—

Countries

India

Contacts

Public ContactDr Garima Singh

Pt. Khushilal Sharma Government Autonomous Ayurveda College and Institute Bhopal (M.P.)

skamini382@gmail.com8770037353

Outcome results